A Study of Alpharadin With Docetaxel in Patients With Bone Metastasis From Castration-Resistant Prostate Cancer (CRPC)

Clinical trial NCT01106352 · COMPLETED

Trial details

NCT number: NCT01106352
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Bone Metastases Castration-Resistant Prostate Cancer

Start date: 2010-07-01
Primary completion: 2015-06-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.